Multiallergen nasal challenges in nonallergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 100, Issue 6, 2008, Pages 533-537

  Wierzbicki, Dania A ^a   Majmundar, Amee R ^b   Schull, Diane E ^c   Khan, David A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Advanced Allergy and Asthma Care SC   (United States)

^c PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GLYCEROL;

ADULT; ALTERNARIA; ARTICLE; CLINICAL ARTICLE; COCKROACH; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; EOSINOPHIL COUNT; FEMALE; HUMAN; INSPIRATORY CAPACITY; MALE; PHLEUM PRATENSE; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; VASOMOTOR RHINITIS;

EID: 45149109628     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60051-8     Document Type: Article

References (30)

1. Ayars G. Nonallergic rhinitis. Immunol Allergy Clin North Am. 2000;20:283-302.
2. Van Rijswijk JB, Blom HM, Fokkens WJ. Idiopathic rhinitis. Allergy. 2005;60:1471-1481.
3. Powe DG, Huskisson RS, Carney AS, Jenkins D, Jones NS. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy. 2001;31:864-872.
4. Powe DG, Jagger C, Kleinjan A, Carney AS, Jenkins D, Jones NS. "Entopy": localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy. 2003;33:1374-1379.
5. Huggins KG, Brostoff J. Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests. Lancet. 1975;2:148-150.
6. Carney AS, Powe DG, Huskisson RS, Jones NS. Atypical nasal challenges in patients with idiopathic rhinitis: more evidence for the existence of allergy in the absence of atopy? Clin Exp Allergy. 2002;32:1436-1440.
7. Bousquet J, Lebel B, Dhivert H, Bataille Y, Martinot B, Michel FB. Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy. Clin Allergy. 1987;17:529-536.
8. Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol. 1988;82:869-877.
9. Nelson HS, Oppenheimer J, Buchmeier A, Kordash TR, Freshwater LL. An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass. J Allergy Clin Immunol. 1996;97:1193-1201.
10. Lent AM, Harbeck R, Strand M, et al. Immunologic response to administration of standardized dog allergen extract at differing doses. J Allergy Clin Immunol. 2006;118:1249-1256.
11. Schwindt CD, Hutcheson PS, Leu SY, Dykewicz MS. Role of intradermal skin tests in the evaluation of clinically relevant respiratory allergy assessed using patient history and nasal challenges. Ann Allergy Asthma Immunol. 2005;94:627-633.
12. Litvyakavo LI, Baraniuk JN. Nasal provocation testing: a review. Ann Allergy Asthma Immunol. 2001;86:355-365.
13. Erin EM, Zacarasiewicz AS, Nicholson GC, et al. Topical corticosteroid inhibits interleukin-4, -5, and -13 in nasal secretions following allergen challenge. Clin Exp Allergy. 2005;35:1608-1614.
14. Nanda A, O'Connor M, Anand M, et al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol. 2004;114:1339-1344.
15. Van Wijk RG, Van Toorenenbergen AW, Zijlstr FJ, Jansen PH, Dieges PH. Nasal hyperreactivity and its effect on early and late sequelae of nasal challenge with house-dust mite extract. Allergy Proc. 1993;14:73-281.
16. Wilson A. Airflow obstruction and peak nasal inspiratory flow. http://www.clementclarke.com/products/inspiratory_flow/in-check_nasal/ pnif_review/index.html. November 19, 2003
17. Barnes ML, Biallosterski BT, Fjihara S, Gray RD, Fardon TC, Lipworth BJ. Effects of intranasal corticosteroid on nasal adenosine monophosphate challenge in persistent allergic rhinitis. Allergy. 2006;61:1319-1325.
18. Alrawi SJ, Tan D, Stoler DL, et al. Tissue eosinophilic infiltration: a useful marker for assessing stromal invasion, survival and locoregional recurrence in head and neck squamous neoplasia. Cancer J. 2005;11:217-225.
19. Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313-319.
20. Krayenbuhl MC, Hudspith BN, Scadding GK, Brostoff J. Nasal response to allergen and hyperosmolar challenge. Clin Allergy. 1988;18:157-164.
21. Rondon C, Romero JJ, Lopez S, et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol. 2007;119:899-905.
22. Starling-Schwanz R, Peake HL, Salome CM, et al. Repeatability of peak nasal inspiratory flow measurements and utility for assessing the severity of rhinitis. Allergy. 2005;60:795-800.
23. Holmstrom M, Scadding GK, Lund VJ, et al. Assessment of nasal obstruction: a comparison between rhinomanometry and nasal inspiratory peak flow. Rhinology. 1990;28:191-196.
24. Jones AS, Viani L, Phillips D, et al. The objective assessment of nasal patency. Clin Otolaryngol. 1991;16:206-211.
25. Ganslmayer M, spertini F, Rahm F, et al. Evaluation of acoustic rhinometry in a nasal provocation test with allergen. Allergy. 1999;54:974-979.
26. Wilson AM, Sims EJ, Robb F, et al. Peak inspiratory flow rate is more sensitive than acoustic rhinometry or rhinomanometry in detecting corticosteroid response with nasal histamine challenge. Rhinology. 2003;41:16-20.
27. Fairley JW, Durham LH, Ell SR. Correlation of subjective sensation of nasal patency with nasal inspiratory peak flow rate. Clin Otolaryngol. 1993;18:19-22.
28. Wilson AM, Dempsey OJ, Seims EJ, et al. Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2000;85:111-114.
29. Osterballe O. Nasal and skin sensitivity during immunotherapy with two major allergens 19, 25 and partially purified extract of timothy grass pollen. Allergy. 1982;37:169-177.
30. White A, Bigby T, Stevenson D. Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2006;97:190-195.